Prior results with the drug in other surgical settings have been mixed ...

P.S.S. Urology, Inc. (“P.S.S. Urology”), a next-generation U.S. medical device distributor delivering clinically proven, cost-efficient solutions for urologic care, today announced the launch of its ...

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

Scientific advances have transformed how we treat cancer over the last decade. The advent of new types of cancer therapies, including targeted therapies and immunotherapies, have resulted in outcomes ...

The rising prevalence of urologic cancers, along with the increased use of hormone therapies and the approval of novel biologics, is driving strong growth in the urologic cancer market globally ...

Across the healthcare industry, the combination of an aging workforce, an aging population, and advancements in disease management has led to a growing demand for physicians that’s rapidly outpacing ...

MERIDIAN, Idaho — A new, less invasive prostate cancer treatment is now available through the Idaho Urologic Institute. It is called the High-Intensity Focused Ultrasound, or HIFU for short. It uses ...

Personalized treatment for urologic cancers involves bladder preservation or partial nephrectomy, considering tumor characteristics and patient health to maximize quality of life and organ function.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal ...

UroGen’s purpose is to provide patients with better alternatives for the treatment of urologic cancers, specificially urothelial cancer, through the use of its novel proprietary RTGel™ technology.

Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype The surgical work force distribution at the county ...